| Form Type | Company Name | Received |
|
PRE 14A
| CEL SCI CORP |
1/25/2013
|
|
8-K
| BIOTA PHARMACEUTICALS, INC. |
1/25/2013
|
|
8-K/A
| BIOTA PHARMACEUTICALS, INC. |
1/23/2013
|
|
N-CSR
| TFS CAPITAL INVESTMENT TRUST |
1/8/2013
|
|
N-CSR
| GOLDMAN SACHS TRUST |
1/4/2013
|
|
N-CSR
| SCHWAB CAPITAL TRUST |
1/3/2013
|
|
DEFM14A
| MYREXIS, INC. |
12/14/2012
|
|
10-K
| CEL SCI CORP |
12/14/2012
|
|
8-K
| BIOTA PHARMACEUTICALS, INC. |
12/11/2012
|
|
N-CSRS
| NORTHERN FUNDS |
12/7/2012
|
|
SC 13G
| BIOTA PHARMACEUTICALS, INC. |
12/5/2012
|
|
13F-HR/A
| STEVENS CAPITAL MANAGEMENT LP |
11/30/2012
|
|
13F-HR/A
| STEVENS CAPITAL MANAGEMENT LP |
11/30/2012
|
|
N-Q
| VANGUARD INSTITUTIONAL INDEX FUNDS |
11/30/2012
|
|
N-Q
| VANGUARD INDEX FUNDS |
11/30/2012
|
|
N-Q
| GOLDMAN SACHS VARIABLE INSURANCE TRUST |
11/29/2012
|
|
N-Q
| VANTAGEPOINT FUNDS |
11/29/2012
|
|
N-Q
| VANGUARD VALLEY FORGE FUNDS |
11/29/2012
|
|
N-Q
| VARIABLE INSURANCE PRODUCTS FUND II |
11/29/2012
|
|
SC 13G
| BIOTA PHARMACEUTICALS, INC. |
11/29/2012
|
|